CRISPR, BiotechnologyCRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers100% left coverage1 source
CRISPR, BiotechnologyCRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers100% left coverage1 source
CRISPR, BiotechnologyJapanese Court Upholds UC CRISPR Patent in Global Legal Battle100% left coverage1 source
CRISPR, BiotechnologyJapanese Court Upholds UC CRISPR Patent in Global Legal Battle100% left coverage1 source
CRISPR, BiotechnologyCRISPR Center Launches with $20M to Develop Personalized Therapies100% left coverage2 sources
CRISPR, BiotechnologyCRISPR Center Launches with $20M to Develop Personalized Therapies100% left coverage2 sources
CRISPR, BiotechnologyCRISPR Therapeutics Named to TIME 100 Most Influential Companies List100% left coverage1 source
CRISPR, BiotechnologyCRISPR Therapeutics Named to TIME 100 Most Influential Companies List100% left coverage1 source
CRISPR, BiotechnologyCRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results100% left coverage1 source
CRISPR, BiotechnologyCRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results100% left coverage1 source
CRISPR, BiotechnologyGAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO100% left coverage1 source
CRISPR, BiotechnologyGAMMA Investing LLC Dramatically Increases Stakes in CRISPR Therapeutics, Structure Therapeutics, REGENXBIO100% left coverage1 source
CRISPR, Business LeadersScientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans100% center coverage1 source
CRISPR, Business LeadersScientists Develop Large-Scale Precise Gene-Editing Tools Across Plants, Humans100% center coverage1 source